Resource Center
Protocols, case studies, webinars, articles and company news in one place.
Case Studies
How research teams have used Sanguine samples and services.
Showing 13 of 13 case studies
-
Process development: replicating the final cell therapy product
Disease-state leukopaks are effective surrogates for establishing cell therapy manufacturing parameters.
-
Isolating rare cell types from peripheral blood
Leukopaks from patients provide large pools of PBMCs.
-
Expanding the reach of clinical trials
Immunogenicity biomarkers in individuals previously infected with COVID-19 were used to evaluate vaccines in preclinical and clinical trials.
-
Linking a drug mechanism to a human disease
A specific autoimmune indication was identified for a novel therapy using patient donor biospecimens.
-
Describing the patient experience in biomarkers
A prospective, longitudinal study using in-home collected biospecimens identified a panel of predictive biomarkers.
-
Hybrid by Design: Patient Centricity in Clinical Trials
As an X-linked disorder, Duchenne’s muscular dystrophy (DMD) primarily affects males, with an incidence of one in every…
-
Easing Participation Burden for Families with Crohn’s Disease
The increasing prevalence of Crohn's disease (CD), an inflammatory bowel disease, drives increased scientific interest in understanding its…
-
Scores for Stratification: Systemic Lupus Erythematosus
The broad spectrum of clinical manifestations seen in systemic lupus erythematosus (SLE) makes it challenging to characterize the…
-
From Serum to Survey – Following an active COVID-19 Patient member community over time
Sanguine Bioscience, a California-based biotechnology company focused on patient recruitment, sample collection engagement and digital health, has partnered…
-
Longitudinal Research Leads the Way: Chronic Hepatitis B
Hepatitis B virus (HBV) is the world’s most common cause of chronic viral infection. Individuals may become infected…
-
Longitudinal Sampling for a Lifelong Disease: Systemic Lupus Erythematosus
As a chronic autoimmune disease, patients with systemic lupus erythematosus (SLE) experience widespread inflammation and unpredictable disease flare…
-
Care About Rare: A Patient-Led Approach to Rare Disease Research
With approximately 30 million people living with roughly 7,000 identified rare diseases in the U.S., translating research to…
-
Need for Speed: Same-Day Sample Collection and Delivery
Partnering with a leading pharmaceutical company in their quest to identify novel biomarkers of RA for therapeutic targeting,…
Couldn't load more resources.
Need research-ready samples instead?
Browse in-stock biospecimens, or tell us what your study needs and we'll scope it.